Bionano Genomics, Inc. Income Statement

Income Statement Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 9.51M12.00M10.13M8.50M17.98M27.80M36.12M30.78M
Cost of Revenue 6.03M8.71M6.77M5.73M14.11M21.86M26.55M30.40M
Gross Profit 3.47M3.29M3.36M2.77M3.87M5.95M9.57M0.38M
Operating items
Research & Development 12.01M9.48M9.08M10.26M22.48M49.05M54.03M24.80M
Selling, General & Administrative 14.08M14.22M20.16M31.07M58.49M88.60M92.76M51.85M
Other Operating Expenses 0.60M78.02M27.70M
Operating Expenses 26.69M23.70M29.24M41.32M80.97M137.64M224.81M104.36M
Operating Income -23.22M-20.42M-25.87M-38.55M-77.10M-131.70M-215.25M-103.98M
EBIT -23.22M-20.42M-25.87M-38.55M-77.10M-131.70M-215.25M-103.98M
Non-operating items
Interest & Investment Income 0.24M1.51M3.31M2.10M
Other Non Operating Income -0.34M-1.33M-0.01M-2.10M-0.22M-20.50M-10.10M
Non Operating Income -0.13M1.93M-3.92M-2.53M-1.05M0.99M-20.50M-10.10M
Net income details
EBT -23.35M-18.48M-29.79M-41.08M-78.15M-130.71M-232.43M-111.98M
Tax Provisions 0.02M0.02M0.02M0.03M-5.72M1.88M0.06M0.03M
Profit After Tax -23.37M-18.50M-29.82M-41.11M-72.44M-132.60M-232.49M-112.02M
Income from Continuing Operations -23.37M-18.50M-29.82M-41.11M-72.44M-132.60M-232.49M-112.02M
Consolidated Net Income -23.37M-18.50M-29.82M-41.11M-72.44M-132.60M-232.49M-112.02M
Income towards Parent Company -23.37M-18.50M-29.82M-41.11M-72.44M-132.60M-232.49M-112.02M
Net Income towards Common Stockholders -23.37M-18.50M-29.82M-41.11M-72.44M-132.60M-232.49M-112.02M
Additional items
EPS (Basic) -8.65-2.61-1.99-0.39-0.26-4.58-408.60-88.13
EPS (Weighted Average and Diluted) -0.26-4.58-408.60-88.13
Shares Outstanding (Weighted Average) 0.02M0.04M0.26M0.48M0.49M0.65M1.70M
Shares Outstanding (Diluted Average) 276.78M28.92M0.57M1.27M
EBITDA -23.22M-20.42M-25.87M-38.55M-77.10M-131.70M-215.25M-103.98M
Interest Expenses 0.59M1.38M2.29M2.52M0.93M0.30M5.12M
Tax Rate 7.32%